Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages

  Khan, Waseem ^a   Sullivan, Kevin L ^a   McCann, Jeffrey W ^a   Gonsalves, Carin F ^a,b   Sato, Takami ^a,b   Eschelman, David J ^a,b   Brown, Daniel B ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chemoembolization complications; Moxifloxacin; Prophylaxis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARMUSTINE; CEFAZOLIN; CIPROFLOXACIN; CISPLATIN; DOXORUBICIN; ERYTHROMYCIN; GEMCITABINE; LEVOFLOXACIN; METRONIDAZOLE; MITOMYCIN C; MOXIFLOXACIN; NEOMYCIN; STREPTOZOCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BILE DUCT STENT; CANCER CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOMES RESEARCH; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; STENT; TREATMENT DURATION; UVEA MELANOMA;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; AZA COMPOUNDS; BILIARY TRACT DISEASES; CASE-CONTROL STUDIES; CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; ETHIODIZED OIL; FEMALE; HUMANS; LIVER ABSCESS; LIVER NEOPLASMS; MALE; PILOT PROJECTS; QUINOLINES; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960741389     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6019     Document Type: Article

References (9)

1. Brown DB, Cardella JF, Sacks D, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2009; 20[7 suppl]:S219-S226
2. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12:965-968 (Pubitemid 32756867)
3. Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 2002; 13:1163-1166 (Pubitemid 35332903)
4. Patel S, Tuite CM, Mondschein JI, Soulen MC. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention. J Vasc Interv Radiol 2006; 17:1931-1934 (Pubitemid 46360674)
5. Schwab D, Grauer M, Hahn EG, Muhldorfer S. Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract. Aliment Pharmacol Ther 2005; 22:417-422 (Pubitemid 41248108)
6. Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12:313-320
7. Stein GE, Schooley S, Tyrrell KL, Citron DM, Nicolau DP, Goldstein EJ. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. Anaerobe 2008; 14:8-12 (Pubitemid 351221367)
8. Ehrenpreis ED. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment Pharmacol Ther 2009; 29:1202-1211
9. Gallagher JC, Du JK, Rose C. Severe pseudomembranous colitis after moxifloxacin use: a case series. Ann Pharmacother 2009; 43:123-128